Cyanvac Llc
Clinical trials sponsored by Cyanvac Llc, explained in plain language.
-
Nasal spray vaccine aims to stop COVID at the nose
⭐️ VACCINE ⭐️ OngoingThis study tests a new COVID-19 vaccine given as a single nasal spray. It aims to see if it is safe and triggers a strong immune response. About 227 healthy adults aged 18 to 80 are taking part. The vaccine is designed to fight the virus right where it enters the body.
Phase: PHASE2 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 07:45 UTC
-
Nasal spray mumps vaccine trial launches in healthy adults
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests two new nasal spray vaccines (CVM150 and CVM26) designed to protect against mumps. About 60 healthy adults aged 18-29 will receive the vaccine and be monitored for side effects and immune response over 12 months. The goal is to see if these vaccines a…
Phase: PHASE1 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 07:35 UTC
-
Nasal spray vaccine aims to block COVID-19 without a needle
⭐️ VACCINE ⭐️ OngoingThis study tests a single-dose nasal spray COVID-19 vaccine (CVXGA) against a standard mRNA shot in about 432 healthy adults who have already had a primary COVID-19 vaccine series. The goal is to see if the nasal vaccine is safer and better at preventing symptomatic COVID-19 over…
Phase: PHASE2 • Sponsor: CyanVac LLC • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 07:21 UTC